nodes	percent_of_prediction	percent_of_DWPC	metapath
Naftifine—SQLE—Cholesterol Biosynthesis—HMGCR—type 2 diabetes mellitus	0.0225	0.0563	CbGpPWpGaD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—ACACA—type 2 diabetes mellitus	0.0195	0.0489	CbGpPWpGaD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—NCOA6—type 2 diabetes mellitus	0.0177	0.0443	CbGpPWpGaD
Naftifine—SQLE—Cholesterol biosynthesis—HMGCR—type 2 diabetes mellitus	0.0165	0.0414	CbGpPWpGaD
Naftifine—SQLE—islet of Langerhans—type 2 diabetes mellitus	0.0162	0.184	CbGeAlD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—ACACA—type 2 diabetes mellitus	0.0156	0.039	CbGpPWpGaD
Naftifine—SQLE—Statin Pathway—LIPC—type 2 diabetes mellitus	0.0152	0.0381	CbGpPWpGaD
Naftifine—SQLE—Statin Pathway—CETP—type 2 diabetes mellitus	0.0147	0.0367	CbGpPWpGaD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA6—type 2 diabetes mellitus	0.0141	0.0354	CbGpPWpGaD
Naftifine—Burning sensation—Bromocriptine—type 2 diabetes mellitus	0.014	0.0289	CcSEcCtD
Naftifine—SQLE—retina—type 2 diabetes mellitus	0.0139	0.157	CbGeAlD
Naftifine—SQLE—Statin Pathway—HMGCR—type 2 diabetes mellitus	0.0133	0.0332	CbGpPWpGaD
Naftifine—SQLE—SREBP signalling—ACACA—type 2 diabetes mellitus	0.0126	0.0316	CbGpPWpGaD
Naftifine—SQLE—pancreas—type 2 diabetes mellitus	0.0114	0.129	CbGeAlD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—SREBF1—type 2 diabetes mellitus	0.0105	0.0264	CbGpPWpGaD
Naftifine—SQLE—adipose tissue—type 2 diabetes mellitus	0.0103	0.117	CbGeAlD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—HMGCR—type 2 diabetes mellitus	0.0102	0.0257	CbGpPWpGaD
Naftifine—Agranulocytosis—Tolbutamide—type 2 diabetes mellitus	0.01	0.0206	CcSEcCtD
Naftifine—SQLE—Statin Pathway—APOB—type 2 diabetes mellitus	0.00971	0.0243	CbGpPWpGaD
Naftifine—SQLE—Statin Pathway—LPL—type 2 diabetes mellitus	0.00927	0.0232	CbGpPWpGaD
Naftifine—Agranulocytosis—Tolazamide—type 2 diabetes mellitus	0.00911	0.0188	CcSEcCtD
Naftifine—Agranulocytosis—Chlorpropamide—type 2 diabetes mellitus	0.00911	0.0188	CcSEcCtD
Naftifine—SQLE—SREBP signalling—PRKAA1—type 2 diabetes mellitus	0.00882	0.0221	CbGpPWpGaD
Naftifine—SQLE—SREBP signalling—RBP4—type 2 diabetes mellitus	0.00852	0.0213	CbGpPWpGaD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—SREBF1—type 2 diabetes mellitus	0.00841	0.0211	CbGpPWpGaD
Naftifine—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00839	0.0173	CcSEcCtD
Naftifine—Dermatitis bullous—Glimepiride—type 2 diabetes mellitus	0.00821	0.0169	CcSEcCtD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—HMGCR—type 2 diabetes mellitus	0.00818	0.0205	CbGpPWpGaD
Naftifine—SQLE—Statin Pathway—APOE—type 2 diabetes mellitus	0.00777	0.0195	CbGpPWpGaD
Naftifine—SQLE—Statin Pathway—APOA1—type 2 diabetes mellitus	0.00768	0.0192	CbGpPWpGaD
Naftifine—Erythema—Tolazamide—type 2 diabetes mellitus	0.00763	0.0157	CcSEcCtD
Naftifine—Leukopenia—Tolbutamide—type 2 diabetes mellitus	0.00751	0.0154	CcSEcCtD
Naftifine—Stinging—Losartan—type 2 diabetes mellitus	0.00734	0.0151	CcSEcCtD
Naftifine—Burning sensation—Ramipril—type 2 diabetes mellitus	0.00734	0.0151	CcSEcCtD
Naftifine—Erythema—Acarbose—type 2 diabetes mellitus	0.00733	0.0151	CcSEcCtD
Naftifine—SQLE—liver—type 2 diabetes mellitus	0.00725	0.0823	CbGeAlD
Naftifine—Leukopenia—Tolazamide—type 2 diabetes mellitus	0.00683	0.0141	CcSEcCtD
Naftifine—Leukopenia—Chlorpropamide—type 2 diabetes mellitus	0.00683	0.0141	CcSEcCtD
Naftifine—SQLE—SREBP signalling—SREBF1—type 2 diabetes mellitus	0.00681	0.0171	CbGpPWpGaD
Naftifine—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.00679	0.077	CbGeAlD
Naftifine—Dermatitis bullous—Glyburide—type 2 diabetes mellitus	0.00677	0.0139	CcSEcCtD
Naftifine—SQLE—SREBP signalling—HMGCR—type 2 diabetes mellitus	0.00663	0.0166	CbGpPWpGaD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—PPARA—type 2 diabetes mellitus	0.00633	0.0159	CbGpPWpGaD
Naftifine—Erythema—Repaglinide—type 2 diabetes mellitus	0.00612	0.0126	CcSEcCtD
Naftifine—Swelling—Valsartan—type 2 diabetes mellitus	0.00605	0.0124	CcSEcCtD
Naftifine—Agranulocytosis—Glipizide—type 2 diabetes mellitus	0.00605	0.0124	CcSEcCtD
Naftifine—Agranulocytosis—Glimepiride—type 2 diabetes mellitus	0.00564	0.0116	CcSEcCtD
Naftifine—Dermatitis bullous—Valsartan—type 2 diabetes mellitus	0.00559	0.0115	CcSEcCtD
Naftifine—Dermatitis bullous—Orlistat—type 2 diabetes mellitus	0.00552	0.0114	CcSEcCtD
Naftifine—Leukopenia—Repaglinide—type 2 diabetes mellitus	0.00548	0.0113	CcSEcCtD
Naftifine—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.00547	0.062	CbGeAlD
Naftifine—Swelling—Irbesartan—type 2 diabetes mellitus	0.0052	0.0107	CcSEcCtD
Naftifine—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	0.00518	0.0107	CcSEcCtD
Naftifine—Erythema—Glipizide—type 2 diabetes mellitus	0.00506	0.0104	CcSEcCtD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—type 2 diabetes mellitus	0.00505	0.0127	CbGpPWpGaD
Naftifine—SQLE—SREBP signalling—SIRT1—type 2 diabetes mellitus	0.00492	0.0123	CbGpPWpGaD
Naftifine—Swelling—Losartan—type 2 diabetes mellitus	0.00489	0.0101	CcSEcCtD
Naftifine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00484	0.00997	CcSEcCtD
Naftifine—Rash—Miglitol—type 2 diabetes mellitus	0.0048	0.00988	CcSEcCtD
Naftifine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.0048	0.00987	CcSEcCtD
Naftifine—SIGMAR1—pancreas—type 2 diabetes mellitus	0.00477	0.0541	CbGeAlD
Naftifine—Erythema—Glimepiride—type 2 diabetes mellitus	0.00473	0.00972	CcSEcCtD
Naftifine—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.00468	0.0531	CbGeAlD
Naftifine—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.00465	0.00957	CcSEcCtD
Naftifine—SQLE—SREBP signalling—LPL—type 2 diabetes mellitus	0.00463	0.0116	CbGpPWpGaD
Naftifine—Leukopenia—Glipizide—type 2 diabetes mellitus	0.00453	0.00932	CcSEcCtD
Naftifine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00441	0.00907	CcSEcCtD
Naftifine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00441	0.00907	CcSEcCtD
Naftifine—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.00433	0.0491	CbGeAlD
Naftifine—Rash—Tolbutamide—type 2 diabetes mellitus	0.00432	0.00888	CcSEcCtD
Naftifine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00429	0.00882	CcSEcCtD
Naftifine—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.00423	0.0087	CcSEcCtD
Naftifine—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.00418	0.0086	CcSEcCtD
Naftifine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00412	0.00847	CcSEcCtD
Naftifine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00412	0.00847	CcSEcCtD
Naftifine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00408	0.0084	CcSEcCtD
Naftifine—Terbinafine—CYP11A1—type 2 diabetes mellitus	0.00399	0.149	CrCbGaD
Naftifine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00393	0.00808	CcSEcCtD
Naftifine—Rash—Tolazamide—type 2 diabetes mellitus	0.00393	0.00808	CcSEcCtD
Naftifine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.0039	0.00803	CcSEcCtD
Naftifine—Headache—Tolazamide—type 2 diabetes mellitus	0.0039	0.00803	CcSEcCtD
Naftifine—Erythema—Glyburide—type 2 diabetes mellitus	0.0039	0.00802	CcSEcCtD
Naftifine—Rash—Linagliptin—type 2 diabetes mellitus	0.00389	0.008	CcSEcCtD
Naftifine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00388	0.00799	CcSEcCtD
Naftifine—Headache—Linagliptin—type 2 diabetes mellitus	0.00386	0.00795	CcSEcCtD
Naftifine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00382	0.00785	CcSEcCtD
Naftifine—Rash—Acarbose—type 2 diabetes mellitus	0.00377	0.00776	CcSEcCtD
Naftifine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00377	0.00776	CcSEcCtD
Naftifine—Rash—Nateglinide—type 2 diabetes mellitus	0.00364	0.00749	CcSEcCtD
Naftifine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00364	0.00748	CcSEcCtD
Naftifine—Pain—Glipizide—type 2 diabetes mellitus	0.00353	0.00727	CcSEcCtD
Naftifine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00353	0.00727	CcSEcCtD
Naftifine—Erythema—Gliclazide—type 2 diabetes mellitus	0.0035	0.0072	CcSEcCtD
Naftifine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00349	0.00718	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.0034	0.00853	CbGpPWpGaD
Naftifine—SQLE—SREBP signalling—PPARG—type 2 diabetes mellitus	0.00338	0.00848	CbGpPWpGaD
Naftifine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00334	0.00687	CcSEcCtD
Naftifine—SQLE—SREBP signalling—INS—type 2 diabetes mellitus	0.00332	0.00832	CbGpPWpGaD
Naftifine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.0033	0.00679	CcSEcCtD
Naftifine—Pain—Sitagliptin—type 2 diabetes mellitus	0.00329	0.00676	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.00323	0.00808	CbGpPWpGaD
Naftifine—Rash—Repaglinide—type 2 diabetes mellitus	0.00315	0.00648	CcSEcCtD
Naftifine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00315	0.00647	CcSEcCtD
Naftifine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00313	0.00644	CcSEcCtD
Naftifine—Headache—Repaglinide—type 2 diabetes mellitus	0.00313	0.00644	CcSEcCtD
Naftifine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00312	0.00642	CcSEcCtD
Naftifine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.00311	0.00639	CcSEcCtD
Naftifine—SIGMAR1—liver—type 2 diabetes mellitus	0.00304	0.0345	CbGeAlD
Naftifine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00298	0.00612	CcSEcCtD
Naftifine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00297	0.00612	CcSEcCtD
Naftifine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00296	0.00608	CcSEcCtD
Naftifine—Erythema—Metformin—type 2 diabetes mellitus	0.00293	0.00602	CcSEcCtD
Naftifine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00292	0.00602	CcSEcCtD
Naftifine—Erythema—Irbesartan—type 2 diabetes mellitus	0.00276	0.00568	CcSEcCtD
Naftifine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00273	0.00562	CcSEcCtD
Naftifine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00273	0.00561	CcSEcCtD
Naftifine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00266	0.00548	CcSEcCtD
Naftifine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00262	0.00539	CcSEcCtD
Naftifine—Rash—Glipizide—type 2 diabetes mellitus	0.00261	0.00536	CcSEcCtD
Naftifine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.0026	0.00536	CcSEcCtD
Naftifine—Erythema—Losartan—type 2 diabetes mellitus	0.0026	0.00535	CcSEcCtD
Naftifine—Headache—Glipizide—type 2 diabetes mellitus	0.00259	0.00533	CcSEcCtD
Naftifine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00255	0.00525	CcSEcCtD
Naftifine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00254	0.00523	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.00251	0.00629	CbGpPWpGaD
Naftifine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00248	0.0051	CcSEcCtD
Naftifine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00247	0.00509	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.00244	0.00613	CbGpPWpGaD
Naftifine—Pain—Gliclazide—type 2 diabetes mellitus	0.00244	0.00502	CcSEcCtD
Naftifine—Rash—Glimepiride—type 2 diabetes mellitus	0.00243	0.005	CcSEcCtD
Naftifine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00243	0.005	CcSEcCtD
Naftifine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00242	0.00499	CcSEcCtD
Naftifine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00242	0.00498	CcSEcCtD
Naftifine—Headache—Glimepiride—type 2 diabetes mellitus	0.00242	0.00497	CcSEcCtD
Naftifine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00241	0.00495	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.00233	0.00584	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.00233	0.00584	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.00233	0.00584	CbGpPWpGaD
Naftifine—Leukopenia—Losartan—type 2 diabetes mellitus	0.00233	0.00479	CcSEcCtD
Naftifine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.0023	0.00473	CcSEcCtD
Naftifine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00225	0.00463	CcSEcCtD
Naftifine—Erythema—Ramipril—type 2 diabetes mellitus	0.00223	0.00459	CcSEcCtD
Naftifine—Pain—Orlistat—type 2 diabetes mellitus	0.00222	0.00456	CcSEcCtD
Naftifine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00219	0.00451	CcSEcCtD
Naftifine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00219	0.00451	CcSEcCtD
Naftifine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00218	0.00448	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.00211	0.0053	CbGpPWpGaD
Naftifine—Naphazoline—ADRA2A—type 2 diabetes mellitus	0.00211	0.0787	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.00208	0.00521	CbGpPWpGaD
Naftifine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00202	0.00416	CcSEcCtD
Naftifine—Rash—Glyburide—type 2 diabetes mellitus	0.00201	0.00413	CcSEcCtD
Naftifine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.002	0.00412	CcSEcCtD
Naftifine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.002	0.00411	CcSEcCtD
Naftifine—Headache—Glyburide—type 2 diabetes mellitus	0.00199	0.0041	CcSEcCtD
Naftifine—Pain—Irbesartan—type 2 diabetes mellitus	0.00193	0.00397	CcSEcCtD
Naftifine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00189	0.00389	CcSEcCtD
Naftifine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00186	0.00382	CcSEcCtD
Naftifine—Bedaquiline—CYP3A4—type 2 diabetes mellitus	0.00184	0.0689	CrCbGaD
Naftifine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00183	0.00377	CcSEcCtD
Naftifine—Pain—Losartan—type 2 diabetes mellitus	0.00181	0.00373	CcSEcCtD
Naftifine—Rash—Gliclazide—type 2 diabetes mellitus	0.0018	0.0037	CcSEcCtD
Naftifine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.0018	0.0037	CcSEcCtD
Naftifine—Headache—Gliclazide—type 2 diabetes mellitus	0.00179	0.00368	CcSEcCtD
Naftifine—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.00177	0.0662	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.00177	0.00443	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	0.00177	0.00443	CbGpPWpGaD
Naftifine—Dizziness—Valsartan—type 2 diabetes mellitus	0.00174	0.00357	CcSEcCtD
Naftifine—SQLE—Metabolism—BHMT—type 2 diabetes mellitus	0.00173	0.00434	CbGpPWpGaD
Naftifine—Dizziness—Orlistat—type 2 diabetes mellitus	0.00171	0.00353	CcSEcCtD
Naftifine—Pruritus—Metformin—type 2 diabetes mellitus	0.00169	0.00348	CcSEcCtD
Naftifine—Rash—Valsartan—type 2 diabetes mellitus	0.00165	0.0034	CcSEcCtD
Naftifine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00165	0.0034	CcSEcCtD
Naftifine—Headache—Valsartan—type 2 diabetes mellitus	0.00164	0.00338	CcSEcCtD
Naftifine—Rash—Orlistat—type 2 diabetes mellitus	0.00163	0.00336	CcSEcCtD
Naftifine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00163	0.00336	CcSEcCtD
Naftifine—Headache—Orlistat—type 2 diabetes mellitus	0.00162	0.00334	CcSEcCtD
Naftifine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.0016	0.00328	CcSEcCtD
Naftifine—Dizziness—Metformin—type 2 diabetes mellitus	0.00158	0.00325	CcSEcCtD
Naftifine—SQLE—Metabolism—AANAT—type 2 diabetes mellitus	0.00152	0.0038	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PTGDS—type 2 diabetes mellitus	0.00152	0.0038	CbGpPWpGaD
Naftifine—Rash—Metformin—type 2 diabetes mellitus	0.00151	0.0031	CcSEcCtD
Naftifine—Dermatitis—Metformin—type 2 diabetes mellitus	0.00151	0.0031	CcSEcCtD
Naftifine—Pruritus—Losartan—type 2 diabetes mellitus	0.0015	0.00309	CcSEcCtD
Naftifine—Headache—Metformin—type 2 diabetes mellitus	0.0015	0.00308	CcSEcCtD
Naftifine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00149	0.00307	CcSEcCtD
Naftifine—Terbinafine—CYP1A2—type 2 diabetes mellitus	0.00146	0.0547	CrCbGaD
Naftifine—Duloxetine—HTR2C—type 2 diabetes mellitus	0.00146	0.0547	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.00144	0.00361	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CDO1—type 2 diabetes mellitus	0.00144	0.0036	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GPD2—type 2 diabetes mellitus	0.00144	0.0036	CbGpPWpGaD
Naftifine—Rash—Irbesartan—type 2 diabetes mellitus	0.00142	0.00292	CcSEcCtD
Naftifine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00142	0.00292	CcSEcCtD
Naftifine—Headache—Irbesartan—type 2 diabetes mellitus	0.00141	0.00291	CcSEcCtD
Naftifine—Cinacalcet—CYP1A2—type 2 diabetes mellitus	0.00141	0.0526	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.0014	0.00352	CbGpPWpGaD
Naftifine—Dizziness—Losartan—type 2 diabetes mellitus	0.0014	0.00289	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.0014	0.0035	CbGpPWpGaD
Naftifine—SQLE—Metabolism—AK1—type 2 diabetes mellitus	0.00137	0.00343	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.00135	0.00339	CbGpPWpGaD
Naftifine—Rash—Losartan—type 2 diabetes mellitus	0.00134	0.00275	CcSEcCtD
Naftifine—SQLE—SREBP signalling—AKT1—type 2 diabetes mellitus	0.00134	0.00335	CbGpPWpGaD
Naftifine—Dermatitis—Losartan—type 2 diabetes mellitus	0.00134	0.00275	CcSEcCtD
Naftifine—Headache—Losartan—type 2 diabetes mellitus	0.00133	0.00273	CcSEcCtD
Naftifine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00129	0.00265	CcSEcCtD
Naftifine—SQLE—Metabolism—SLC5A4—type 2 diabetes mellitus	0.00126	0.00317	CbGpPWpGaD
Naftifine—SQLE—Metabolism—MAT1A—type 2 diabetes mellitus	0.00126	0.00317	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.00126	0.00316	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.00124	0.0031	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.00123	0.00307	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ND1—type 2 diabetes mellitus	0.00122	0.00306	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ENPP1—type 2 diabetes mellitus	0.00122	0.00306	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HBA2—type 2 diabetes mellitus	0.00122	0.00306	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.00122	0.00306	CbGpPWpGaD
Naftifine—SQLE—Metabolism—G6PC—type 2 diabetes mellitus	0.00122	0.00306	CbGpPWpGaD
Naftifine—Dizziness—Ramipril—type 2 diabetes mellitus	0.0012	0.00248	CcSEcCtD
Naftifine—SQLE—Metabolism—GCGR—type 2 diabetes mellitus	0.00118	0.00296	CbGpPWpGaD
Naftifine—Rash—Ramipril—type 2 diabetes mellitus	0.00115	0.00236	CcSEcCtD
Naftifine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00115	0.00236	CcSEcCtD
Naftifine—Headache—Ramipril—type 2 diabetes mellitus	0.00114	0.00235	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.00114	0.00285	CbGpPWpGaD
Naftifine—Toremifene—CYP1A2—type 2 diabetes mellitus	0.00114	0.0425	CrCbGaD
Naftifine—SQLE—Metabolism—OXCT1—type 2 diabetes mellitus	0.00112	0.0028	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYTB—type 2 diabetes mellitus	0.00112	0.0028	CbGpPWpGaD
Naftifine—Duloxetine—CYP1A2—type 2 diabetes mellitus	0.0011	0.0412	CrCbGaD
Naftifine—SQLE—Metabolism—SRD5A1—type 2 diabetes mellitus	0.00109	0.00273	CbGpPWpGaD
Naftifine—SQLE—Metabolism—STAR—type 2 diabetes mellitus	0.00104	0.0026	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HSD17B3—type 2 diabetes mellitus	0.00104	0.0026	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ACACA—type 2 diabetes mellitus	0.00104	0.0026	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CBS—type 2 diabetes mellitus	0.000996	0.0025	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ABCC8—type 2 diabetes mellitus	0.000996	0.0025	CbGpPWpGaD
Naftifine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.000984	0.0368	CrCbGaD
Naftifine—Terbinafine—CYP3A4—type 2 diabetes mellitus	0.000969	0.0362	CrCbGaD
Naftifine—SQLE—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000959	0.0024	CbGpPWpGaD
Naftifine—SQLE—Metabolism—COX2—type 2 diabetes mellitus	0.000959	0.0024	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NCOA6—type 2 diabetes mellitus	0.000942	0.00236	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000941	0.00236	CbGpPWpGaD
Naftifine—Cinacalcet—CYP3A4—type 2 diabetes mellitus	0.000933	0.0349	CrCbGaD
Naftifine—SQLE—Metabolism—UCP3—type 2 diabetes mellitus	0.000926	0.00232	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000926	0.00232	CbGpPWpGaD
Naftifine—SQLE—Metabolism—UCP2—type 2 diabetes mellitus	0.000926	0.00232	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000897	0.00225	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PCK1—type 2 diabetes mellitus	0.00087	0.00218	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000857	0.00215	CbGpPWpGaD
Naftifine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.000839	0.0313	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000836	0.0021	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HK1—type 2 diabetes mellitus	0.000815	0.00204	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000814	0.00204	CbGpPWpGaD
Naftifine—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	0.000802	0.03	CrCbGaD
Naftifine—SQLE—Metabolism—LPA—type 2 diabetes mellitus	0.000787	0.00197	CbGpPWpGaD
Naftifine—SQLE—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000787	0.00197	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000787	0.00197	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GCKR—type 2 diabetes mellitus	0.000787	0.00197	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000757	0.0019	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ALDOB—type 2 diabetes mellitus	0.000755	0.00189	CbGpPWpGaD
Naftifine—Toremifene—CYP3A4—type 2 diabetes mellitus	0.000754	0.0282	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000733	0.00184	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000718	0.0018	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.00071	0.00178	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GLP1R—type 2 diabetes mellitus	0.000702	0.00176	CbGpPWpGaD
Naftifine—Tamoxifen—ABCC2—type 2 diabetes mellitus	0.000681	0.0254	CrCbGaD
Naftifine—SQLE—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000655	0.00164	CbGpPWpGaD
Naftifine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	0.000651	0.0243	CrCbGaD
Naftifine—Cinnarizine—CYP1A2—type 2 diabetes mellitus	0.00065	0.0243	CrCbGaD
Naftifine—SQLE—Metabolism—CPT1A—type 2 diabetes mellitus	0.000642	0.00161	CbGpPWpGaD
Naftifine—SQLE—Metabolism—MTR—type 2 diabetes mellitus	0.000642	0.00161	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NAMPT—type 2 diabetes mellitus	0.000629	0.00158	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000626	0.00157	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HBA1—type 2 diabetes mellitus	0.000625	0.00157	CbGpPWpGaD
Naftifine—SQLE—Metabolism—LIPC—type 2 diabetes mellitus	0.000625	0.00157	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GCK—type 2 diabetes mellitus	0.000625	0.00157	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000621	0.00156	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SLC9A1—type 2 diabetes mellitus	0.00061	0.00153	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CETP—type 2 diabetes mellitus	0.000603	0.00151	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000563	0.00141	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PSMD6—type 2 diabetes mellitus	0.000561	0.00141	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SREBF1—type 2 diabetes mellitus	0.000561	0.00141	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SNAP25—type 2 diabetes mellitus	0.000561	0.00141	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CTGF—type 2 diabetes mellitus	0.000551	0.00138	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HMGCR—type 2 diabetes mellitus	0.000546	0.00137	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000538	0.00135	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000534	0.00134	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000513	0.00129	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000507	0.00127	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000507	0.00127	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000495	0.00124	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000492	0.00123	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000486	0.00122	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GCG—type 2 diabetes mellitus	0.000486	0.00122	CbGpPWpGaD
Naftifine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	0.000478	0.0179	CrCbGaD
Naftifine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.000467	0.0174	CrCbGaD
Naftifine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.000464	0.0173	CrCbGaD
Naftifine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	0.000455	0.017	CrCbGaD
Naftifine—SQLE—Metabolism—GNB3—type 2 diabetes mellitus	0.000419	0.00105	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000419	0.00105	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HMOX1—type 2 diabetes mellitus	0.000417	0.00105	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CAT—type 2 diabetes mellitus	0.000412	0.00103	CbGpPWpGaD
Naftifine—SQLE—Metabolism—APOB—type 2 diabetes mellitus	0.0004	0.001	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTM1—type 2 diabetes mellitus	0.000389	0.000974	CbGpPWpGaD
Naftifine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	0.000386	0.0144	CrCbGaD
Naftifine—SQLE—Metabolism—LPL—type 2 diabetes mellitus	0.000382	0.000956	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ADCY5—type 2 diabetes mellitus	0.000374	0.000936	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GPX1—type 2 diabetes mellitus	0.000372	0.000933	CbGpPWpGaD
Naftifine—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	0.000369	0.0138	CrCbGaD
Naftifine—SQLE—Metabolism—CD36—type 2 diabetes mellitus	0.000363	0.000909	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000358	0.000897	CbGpPWpGaD
Naftifine—SQLE—Metabolism—MTHFR—type 2 diabetes mellitus	0.000344	0.000861	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PPARA—type 2 diabetes mellitus	0.000337	0.000845	CbGpPWpGaD
Naftifine—SQLE—Metabolism—AGT—type 2 diabetes mellitus	0.000326	0.000818	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CALM1—type 2 diabetes mellitus	0.000321	0.000804	CbGpPWpGaD
Naftifine—SQLE—Metabolism—APOE—type 2 diabetes mellitus	0.00032	0.000802	CbGpPWpGaD
Naftifine—SQLE—Metabolism—APOA1—type 2 diabetes mellitus	0.000316	0.000792	CbGpPWpGaD
Naftifine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	0.000301	0.0112	CrCbGaD
Naftifine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	0.000292	0.0109	CrCbGaD
Naftifine—SQLE—Metabolism—PPARG—type 2 diabetes mellitus	0.000279	0.000698	CbGpPWpGaD
Naftifine—SQLE—Metabolism—INS—type 2 diabetes mellitus	0.000273	0.000685	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ALB—type 2 diabetes mellitus	0.000251	0.000628	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PIK3R1—type 2 diabetes mellitus	0.00024	0.000601	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NOS3—type 2 diabetes mellitus	0.00024	0.000601	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PTGS2—type 2 diabetes mellitus	0.000219	0.000549	CbGpPWpGaD
Naftifine—SQLE—Metabolism—AKT1—type 2 diabetes mellitus	0.00011	0.000276	CbGpPWpGaD
